Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Exscientia Ltd ADR (EXAI)

Exscientia Ltd ADR (EXAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 527,067
  • Shares Outstanding, K 120,887
  • Annual Sales, $ 24,980 K
  • Annual Income, $ -181,560 K
  • 60-Month Beta 0.78
  • Price/Sales 20.40
  • Price/Cash Flow N/A
  • Price/Book 1.16
Trade EXAI with:

Options Overview Details

View History
  • Implied Volatility 138.83% ( -32.99%)
  • Historical Volatility 75.79%
  • IV Percentile 99%
  • IV Rank 72.10%
  • IV High 171.82% on 04/18/24
  • IV Low 53.59% on 11/02/23
  • Put/Call Vol Ratio 1.05
  • Today's Volume 123
  • Volume Avg (30-Day) 286
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 9,258
  • Open Int (30-Day) 7,800

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +262,994.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.14 +2.42%
on 04/19/24
6.88 -38.33%
on 03/20/24
-1.99 (-31.94%)
since 03/19/24
3-Month
4.14 +2.42%
on 04/19/24
7.91 -46.40%
on 02/12/24
-1.57 (-26.96%)
since 01/19/24
52-Week
4.14 +2.42%
on 04/19/24
9.12 -53.51%
on 08/01/23
-1.40 (-24.82%)
since 04/19/23

Most Recent Stories

More News
Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now

Exscientia has the potential to be a star collaborator and a profitable drug developer, too.

EXAI : 4.24 (-2.75%)
Unlocking AI investment opportunities in healthcare

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

INTC : 34.20 (-2.40%)
NVDA : 762.00 (-10.00%)
RXRX : 7.35 (-0.68%)
RLAY : 5.96 (-2.45%)
EXAI : 4.24 (-2.75%)
RENB : 2.17 (-5.65%)
BTAI : 2.75 (+7.84%)
3 AI Drug Discovery Stocks to Watch

The high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies.

LLY : 726.31 (-2.63%)
SDGR : 24.29 (-0.21%)
RXRX : 7.35 (-0.68%)
EXAI : 4.24 (-2.75%)
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

SDGR : 24.29 (-0.21%)
GOOG : 155.72 (-1.11%)
NVDA : 762.00 (-10.00%)
SAN : 4.75 (unch)
SNY : 46.30 (+2.00%)
SNYNF : 92.7000 (unch)
RXRX : 7.35 (-0.68%)
EXAI : 4.24 (-2.75%)
BMY : 48.93 (+1.30%)
MarketBeat Week in Review – 7/24 - 7/28

Investors continue to look for stocks to buy as inflation cools. As you prepare for another busy week, here are some of our top stories from this week

EXAI : 4.24 (-2.75%)
PSNY : 1.3500 (+1.50%)
MSFT : 399.12 (-1.27%)
CMG : 2,869.11 (-1.34%)
CHKP : 157.95 (-0.27%)
TSLA : 147.05 (-1.92%)
CDNS : 280.25 (-1.98%)
UPS : 142.77 (+0.02%)
LLY : 726.31 (-2.63%)
AI : 20.72 (-0.72%)
RIVN : 8.63 (-2.27%)
PHM : 105.43 (-0.50%)
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential

A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.

EXAI : 4.24 (-2.75%)
MSFT : 399.12 (-1.27%)
NVDA : 762.00 (-10.00%)
RXRX : 7.35 (-0.68%)
RDNT : 46.52 (-2.29%)
SDGR : 24.29 (-0.21%)
Exscientia is the Sniper of the AI Drug Discovery Industry

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

EXAI : 4.24 (-2.75%)
GGRGF : 24.7500 (unch)
SNYNF : 92.7000 (unch)
SNY : 46.30 (+2.00%)
RXRX : 7.35 (-0.68%)
BMY : 48.93 (+1.30%)
NVDA : 762.00 (-10.00%)
SDGR : 24.29 (-0.21%)
SFTBF : 47.6300 (-4.79%)
Why Shares of Exscientia Jumped on Wednesday

The company may be riding the wave of an AI healthcare boom.

NVDA : 762.00 (-10.00%)
SNY : 46.30 (+2.00%)
RXDX : 199.92 (+0.09%)
BYM : 11.06 (+0.18%)
COMP : 3.24 (-0.61%)
EXAI : 4.24 (-2.75%)
Why Shares of Exscientia Soared This Week

The company benefited from a surge in interest in AI-associated stocks.

NVDA : 762.00 (-10.00%)
EXAI : 4.24 (-2.75%)
Why Artificial Intelligence Stock Exscientia Leaped 6% Higher Today

With a white-hot technology as a foundation for its business, the biotech's better-than-expected first-quarter results brought about a bull stampede.

EXAI : 4.24 (-2.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.

See More

Key Turning Points

3rd Resistance Point 4.54
2nd Resistance Point 4.44
1st Resistance Point 4.34
Last Price 4.24
1st Support Level 4.14
2nd Support Level 4.04
3rd Support Level 3.94

See More

52-Week High 9.12
Fibonacci 61.8% 7.22
Fibonacci 50% 6.63
Fibonacci 38.2% 6.04
Last Price 4.24
52-Week Low 4.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar